AMRX vs NVST
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
AMRX presents a stark contrast between operational success and financial instability, evidenced by a stable Piotroski F-Score of 4/9 but a critical Debt/Equity ratio of 450.96. While the company shows explosive YoY EPS growth of 75% and a highly attractive Forward P/E of 10.87, its negative book value and a significant gap between the current price ($12.87) and intrinsic value ($1.54) signal high risk. Analyst sentiment remains strongly bullish with a $17 target, yet insider selling and a bearish technical trend suggest caution. The investment thesis relies entirely on continued earnings acceleration to outpace its precarious balance sheet.
NVST presents a complex profile with a stable Piotroski F-Score of 4/9 and a significant valuation gap, as the current price of $25.94 far exceeds the Graham Number ($10.93) and Intrinsic Value ($8.26). While the company shows strong short-term price momentum (+61.3% 1Y) and a highly attractive Forward P/E of 16.64, its trailing P/E of 92.64 and razor-thin profit margin of 1.73% indicate a precarious transition period. The bullish analyst consensus is countered by bearish insider sentiment and a 0/100 technical trend, suggesting the market is pricing in a recovery that has not yet fully materialized in the fundamentals.
Compare Another Pair
Related Comparisons
AMRX vs NVST: Head-to-Head Comparison
This page compares Amneal Pharmaceuticals, Inc. (AMRX) and Envista Holdings Corporation (NVST) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.